Sudarshan Pharma Industries Ltd. benchmarking: Perfomance to industry peers

Financial

	Sudarshan Pharma Ind	Jenburkt Pharma	Medicamen Biotech
Operational Metrics
Financials
5 yr Average ROE	11.77 %	18.49 %	6.92 %
5yr average Equity Multiplier	3.38	1.17	1.44
5yr Average Asset Turnover Ratio	1.89	0.88	0.55
5yr Avg Net Profit Margin	2.0 %	18.1 %	8.69 %
Price to Book	3.39	2.49	1.76
P/E	29.68	13.83	45.38
5yr Avg Cash Conversion Cycle	121.83 Days	-32.02 Days	49.75 Days
Inventory Days	54.87 Days	24.72 Days	84.58 Days
Days Receivable	102.16 Days	48.38 Days	139.4 Days
Days Payable	70.3 Days	82.6 Days	264.75 Days
5yr Average Interest Coverage Ratio	2.61	87.2	7.03
5yr Avg ROCE	23.07 %	24.44 %	10.34 %
5yr Avg Operating Profit Margin	4.55 %	22.46 %	15.51 %
5 yr average Debt to Equity	0.99	0.02	0.15
5yr CAGR Net Profit	42.99 %	14.21 %	-11.57 %
5yr Average Return on Assets	3.51 %	15.8 %	4.73 %
Shareholdings
Promoter Holding	57.39 %	46.65 %	40.46 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-31.89 %	0.68 %	-2.75 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Sudarshan Pharma Ind	Jenburkt Pharma	Medicamen Biotech
Product Wise Break-Up	Product Wise Break-Up Chemical 100.0 Pharmaceutical 0 Pharmaceuticals 0 Dermatology 0 Pharmaceuticals Formulations 0	Product Wise Break-Up Pharmaceutical 0 Chemical 0 Pharmaceutical 100.0 Pharmaceuticals Formulations 0 Dermatology 0	Product Wise Break-Up Pharmaceutical 0 Chemical 0 Pharmaceuticals 0 Pharmaceuticals Formulations 100.0 Dermatology 0
Location Wise Break-Up	Location Wise Break-Up India 100.0 Rest of the World 0	Location Wise Break-Up India 87.23 Rest of the World 12.56 Others 0.21	Location Wise Break-Up India 20.0 Rest of the World 0 Others 80.0